Dr. Stewart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
University of California Davis HealthResidency, Ophthalmology, 1988 - 1989
Touro InfirmaryResidency, Ophthalmology, 1987 - 1988
Emory University School of MedicineResidency, Ophthalmology, 1984 - 1987
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1983 - 1984
McGill University Faculty of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1988 - Present
FL State Medical License 1989 - 2025
MN State Medical License 2014 - 2017
GA State Medical License 1984 - 1999
LA State Medical License 1987 - 1988- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 10 citationsFUNDUS FINDINGS IN A PATIENT WITH α-METHLYACYL-COA RACEMASE DEFICIENCY.Michael W. Stewart, Michael W Vavra, Nathaniel R Whaley
Retinal Cases & Brief Reports. 2011-01-01 - 29 citationsIndividualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?Michael W. Stewart
Journal of Clinical Medicine. 2015-05-21 - 66 citationsAvastin doesn't blind people, people blind people.Serafin Gonzalez, Philip J. Rosenfeld, Michael W. Stewart, Jennifer C. Brown, Steven P. Murphy
American Journal of Ophthalmology. 2012-02-01
Press Mentions
Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD Meets Primary and Secondary EndpointsJuly 29th, 2019
Physicians' Perspective: Desired Changes Among Retina SpecialistsJuly 29th, 2019
Anti-VEGF Drugs Making a Difference in Vision, Longterm CareJanuary 28th, 2014- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
